220 related articles for article (PubMed ID: 8458362)
21. Quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension.
Lenz T; Schulte KL; Wagner B; Lilienthal J; Gotzen R
Eur Heart J; 1994 Jul; 15(7):940-6. PubMed ID: 7925516
[TBL] [Abstract][Full Text] [Related]
22. Can an angiotensin-converting enzyme inhibitor with a short half-life effectively lower blood pressure for 24 hours?
Palatini P
Am Heart J; 1992 May; 123(5):1421-5. PubMed ID: 1575169
[TBL] [Abstract][Full Text] [Related]
23. Effects of 12 months quinapril therapy in asymptomatic patients with chronic aortic regurgitation.
Schön HR; Dorn R; Barthel P; Schömig A
J Heart Valve Dis; 1994 Sep; 3(5):500-9. PubMed ID: 8000584
[TBL] [Abstract][Full Text] [Related]
24. Quinapril: a new second-generation ACE inhibitor.
Cetnarowski-Cropp AB
DICP; 1991 May; 25(5):499-504. PubMed ID: 2068835
[TBL] [Abstract][Full Text] [Related]
25. The treatment of mild to moderate hypertension with ACE inhibitors.
Taylor SH
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S24-8. PubMed ID: 1691403
[TBL] [Abstract][Full Text] [Related]
26. Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors.
Puig JG; Mateos FA; Ramos TH; Lavilla MP; Capitán MC; Gil A
Am J Hypertens; 1994 Jan; 7(1):46-51. PubMed ID: 8136110
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin converting enzyme inhibitors as initial monotherapy in severe hypertension. Quinapril and captopril.
Frishman WH; Greenberg S
Am J Hypertens; 1991 Oct; 4(10 Pt 1):827-31. PubMed ID: 1747216
[TBL] [Abstract][Full Text] [Related]
28. Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension.
Ding YA; Chang SM; Chou TC
J Hum Hypertens; 1995 Aug; 9(8):637-41. PubMed ID: 8523379
[TBL] [Abstract][Full Text] [Related]
29. The hemodynamics effects of ACE inhibitors in the treatment of congestive heart failure.
Nieminen MS; Kupari M
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S36-40. PubMed ID: 1691405
[TBL] [Abstract][Full Text] [Related]
30. Effects of the converting enzyme inhibitor quinapril (CI-906) on blood pressure, renin-angiotensin system, and prostanoids in essential hypertension.
Säynävälammi P; Pörsti I; Pörsti P; Nurmi AK; Seppälä E; Manninen V; Vapaatalo H
J Cardiovasc Pharmacol; 1988 Jul; 12(1):88-93. PubMed ID: 2459540
[TBL] [Abstract][Full Text] [Related]
31. The management of hypertension in older patients.
Schnaper HW
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S56-61. PubMed ID: 1691408
[TBL] [Abstract][Full Text] [Related]
32. Preliminary hemodynamic report of the efficacy and safety of quinapril in acute and chronic treatment of patients with congestive heart failure.
Banas JS
Angiology; 1989 Apr; 40(4 Pt 2):396-404. PubMed ID: 2705644
[TBL] [Abstract][Full Text] [Related]
33. Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group.
Ostman J; Asplund K; Bystedt T; Dahlöf B; Jern S; Kjellström T; Lithell H
J Intern Med; 1998 Aug; 244(2):95-107. PubMed ID: 10095796
[TBL] [Abstract][Full Text] [Related]
34. The effect of quinapril on functional status of elderly patients with diastolic heart failure.
Zi M; Carmichael N; Lye M
Cardiovasc Drugs Ther; 2003 Mar; 17(2):133-9. PubMed ID: 12975595
[TBL] [Abstract][Full Text] [Related]
35. Does blood pressure reduction necessarily compromise cardiac function or renal hemodynamics? Effects of the angiotensin-converting enzyme inhibitor quinapril.
Kjeldsen SE; Gupta RK; Krause L; Weder AB; Julius S
Am Heart J; 1992 May; 123(5):1433-8. PubMed ID: 1575171
[TBL] [Abstract][Full Text] [Related]
36. The response to the first dose of an angiotensin converting enzyme inhibitor in uncomplicated hypertension--a placebo controlled study utilising ambulatory blood pressure recording.
MacFadyen RJ; Bainbridge AD; Lees KR; Reid JL
Br J Clin Pharmacol; 1991 Sep; 32(3):393-8. PubMed ID: 1777377
[TBL] [Abstract][Full Text] [Related]
37. Overall tolerance and safety of quinapril in clinical trials.
Frank GJ; Knapp LE; McLain RW
Angiology; 1989 Apr; 40(4 Pt 2):405-15. PubMed ID: 2650583
[TBL] [Abstract][Full Text] [Related]
38. Comparative trial of quinapril versus captopril in mild to moderate congestive heart failure. Quinapril/Captopril Congestive Heart Failure Study Group.
Gavazzi A; Marioni R; Campana C; Montemartini C
J Hypertens Suppl; 1994 Jul; 12(4):S89-93. PubMed ID: 7965279
[TBL] [Abstract][Full Text] [Related]
39. [Hemodynamic and humoral effects of parenteral therapy with intravenously administered ACE inhibitor quinaprilat in patients with advanced heart failure].
Mitrovic V; Mudra H; Bonzel T; Schmidt W; Schlepper M
Z Kardiol; 1996 Nov; 85(11):828-38. PubMed ID: 9064945
[TBL] [Abstract][Full Text] [Related]
40. Assessing the clinical need for short-term conversion from oral to parenteral angiotensin converting enzyme inhibitor therapy in hypertensive patients. A quinapril to quinaprilat placebo-controlled model.
Whelton A; McCormick L; Wombolt D; Goldstein R; Canter D
Eur Heart J; 1997 Jan; 18(1):140-7. PubMed ID: 9049526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
